课题基金 / 基金详情

An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease

An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease
阿尔茨海默病 DNA 甲基化、转录组变化和认知功能障碍的综合分析
批准号:
9353721
负责人:
Andrew Franklin Teich
金额:
$21.09万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2019-05-31

项目摘要

项目成果

Andrew Franklin Teich的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Teich, Andrew Franklin Project Summary: This is a training grant that will give me the resources to develop into an academic physician-scientist. My long- term goal is to do research that focuses on Alzheimer's disease (AD) and neurodegenerative diseases of the aging brain, and integrate this with my clinical role as a neuropathologist (with at least 75% of my time dedicated to research). This grant has a scientific proposal component as well as a training component. The scientific proposal component will ask two questions. First, I will ask if there are differences in gene methylation between AD patients and cognitively normal patients with a similar cortical β-amyloid load (“pathological controls”). AD patients have been shown to have abnormalities in DNA methylation, and β- amyloid has also been shown to cause alterations in DNA methylation. However, “pathologic controls” have elevated β-amyloid levels but are not demented. Since pathologic controls have elevated β-amyloid levels, and β-amyloid has been shown to cause altered DNA methylation, pathologic controls may have some DNA methylation abnormalities normally associated with AD that do not directly cause dementia. By comparing AD brain tissue to pathological control tissue, I hope to tease out changes in gene methylation that correlate strongest with the presence of dementia. Second, I will ask whether there are changes in DNA methylation that are predictive of worsening cognitive status in the setting of AD pathology, using a patient population that is being shunted for hydrocephalus. In all, these experiments will help to tease out the association of abnormal DNA methylation with impaired cognition in AD. My PhD thesis was in a computational neuroscience lab (i.e. “dry-lab” work). I have spent the last several years after my clinical training becoming proficient in experimental neuroscience (i.e. “wet-lab” work). This training grant will take advantage of this background and train me in computational techniques of analyzing genomic and genome expression data, with a focus on applying these techniques to neurodegeneration and the aging brain. In addition, this training grant is coinciding with my elevation to Co-Director of the New York Brain Bank at Columbia University. I will accomplish four training goals during the course of this grant; 1) Acquire a skill set to facilitate my new leadership role at Columbia, 2) Acquire the skills to perform computational analysis of genomic and genome expression data, 3) Deepen my knowledge of aging biology, 4) Acquire skills to succeed in writing my first R01 grant. In summary, this training grant, through the scientific proposal and the training plan, will give me the resources to flourish as a scientist and make a contribution to Alzheimer's disease research. 0925-0001/0002 (Rev. 08/12) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuropathology Core
Neuropathology Core
Neuropathology Core
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease